CONMED Corporation Announces Virtual 2020 Annual Meeting of Shareholders
March 31 2020 - 4:05PM
Business Wire
CONMED Corporation (NYSE: CNMD) today announced that the
2020 Annual Meeting of Shareholders will be held on May 21, 2020 at
1:30 p.m. ET. Shareholders as of the close of business on the
record date, April 3, 2020, will be eligible to attend, vote at,
and participate in the Annual Meeting.
Due to an Executive Order prohibiting public gatherings in New
York State amid public health and safety concerns arising from the
COVID-19 pandemic, the 2020 Annual Meeting of Shareholders will be
held virtually.
The State of New York typically requires shareholder meetings to
accommodate in-person attendance; however, a temporary exception to
this rule has been granted. As of the date of this press release,
this exception will remain in place through April 19, 2020. The
Company currently anticipates that this exception will be extended;
however, if legally required by the State to accommodate in-person
attendance, the Company will allow a legally permitted number of
shareholders to attend the Annual Meeting in person on a
first-come, first-served basis. If and when that determination is
made, instructions for how to be considered for in-person
attendance will be communicated in the future on the Company’s web
site and in the Company’s proxy filings.
Information about the virtual meeting webcast and instructions
for how shareholders can participate in the Annual Meeting will be
included in either the definitive proxy statement or a proxy
supplement for the Annual Meeting to be filed with the Securities
and Exchange Commission and available on the investor relations
page of our web site at www.conmed.com/en/about
us/investors/investor relations.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
neurosurgery, thoracic surgery and gastroenterology. For more
information, visit www.conmed.com.
SOLICITATION LEGEND
Additional Information and Where to
Find It
This communication may be deemed to be solicitation material in
respect of the proposals to be voted on in connection with the 2020
annual meeting of shareholders of CONMED Corporation (the
“Company”), including the election of directors. The Company filed
a preliminary proxy statement on Schedule 14A with the Securities
and Exchange Commission (“SEC”) on March 16, 2020 in connection
with the solicitation of proxies for its 2020 annual meeting of
shareholders or any adjournment or postponement thereof (the “2020
Annual Meeting”). The Company intends to file other relevant
materials with the SEC, including a proxy statement in definitive
form, in connection with the 2020 Annual Meeting. This document is
not a substitute for the proxy statement or any other document
which the Company may file with the SEC. SHAREHOLDERS ARE URGED
TO READ THE PROXY STATEMENT, INCLUDING ANY AMENDMENTS OR
SUPPLEMENTS THERETO, AND ALL OTHER RELEVANT DOCUMENTS THAT ARE
FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR
SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY
BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION.
Shareholders may obtain free copies of the proxy statement (when
available) and other documents that the Company files with the SEC
from the SEC’s website at www.sec.gov or the Company’s investor
relations website at
https://www.conmed.com/en/about-us/investors/investor-relations as
soon as reasonably practicable after such materials are
electronically filed with, or furnished to, the SEC.
Participants in the
Solicitation
The Company and certain of its directors and executive officers
may be deemed participants in the solicitation of proxies from
shareholders in connection with the matters to be considered at the
Company’s 2020 Annual Meeting. Certain information regarding these
directors and executive officers and a description of their direct
and indirect interests, by security holdings or otherwise, will be
included in the Company’s definitive proxy statement for the 2020
Annual Meeting and other relevant documents to be filed with the
SEC. Information regarding the Company’s directors and executive
officers is currently available in the Company’s definitive proxy
statement for its 2019 annual meeting of shareholders filed with
the SEC on April 12, 2019 and the Company’s preliminary proxy
statement for the 2020 Annual Meeting filed with the SEC on March
16, 2020. All documents filed by the Company with the SEC will be
available free of charge from the sources indicated above.
Forward-Looking
Statements
This press release may contain forward-looking statements based
on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results, developments and events to
differ materially from those in the forward-looking statements may
include, but are not limited to, the risk factors discussed in the
Company's Annual Report on Form 10-K for the full year ended
December 31, 2019. Any and all forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995 and relate to the Company’s
performance on a going-forward basis. The Company believes that all
forward-looking statements made by it have a reasonable basis, but
there can be no assurance that management’s expectations, beliefs
or projections as expressed in the forward-looking statements will
actually occur or prove to be correct. Forward-looking statements
speak only as of the date made, and the Company disclaims any
obligation to update or revise any forward-looking statements
except as required by applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200331005732/en/
CONMED Corporation Todd Garner Chief Financial
Officer 315-624-3317 ToddGarner@conmed.com
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jul 2023 to Jul 2024